Leslie Bucheit

Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer

Sakti Chakrabarti, Leslie Bucheit, Jason S. Starr et al. · Journal for ImmunoTherapy of Cancer · 2022 · 60 citations · Full text

Medicine, Immunology, Oncology +17

Clinical utility of hereditary cancer panel testing: Impact of <i>PALB2</i>, <i>ATM</i>, <i>CHEK2</i>, <i>NBN</i>, <i>BRIP1</i>, <i>RAD51C</i>, and <i>RAD51D</i> results on patient management and adherence to provider recommendations

Valentina Vysotskaia, Kristjan Eerik Kaseniit, Leslie Bucheit et al. · Cancer · 2019 · 29 citations · Full text

Life Sciences, Genetics, Oncology +17

Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study

Susanna Slater, Annette Bryant, Maria Aresu et al. · Clinical Cancer Research · 2024 · 28 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling

Lorenzo Gerratana, Andrew A. Davis, Lorenzo Foffano et al. · Cancer Letters · 2024 · 22 citations

Medicine, Bioinformatics, Oncology +17

Pan-Cancer Prevalence of Microsatellite Instability-High (MSI-H) Identified by Circulating Tumor DNA and Associated Real-World Clinical Outcomes

Pashtoon Murtaza Kasi, Leslie Bucheit, Jiemin Liao et al. · JCO Precision Oncology · 2023 · 19 citations

Life Sciences, Genetics, Oncology +17